Kuecept present at Procept Spray Drying seminar in Barcelona

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

- Advertisement -

Kuecept were pleased to be invited to present their latest research in the field of spray drying at the Procept Spray Drying Seminar held in Barcelona on the 8th June. With over 50 attendees from more than 15 organisations throughout Europe,…

the conference aimed to give a detailed overview of the theory and practical applications of spray drying in the manufacture of pharmaceutical and biopharmaceutical dosage forms.

If you would like a reprint of the presentation given by Dr Mark Saunders, Development Director at Kuecept, please contact us directly.

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

O-1A Visa Evidence for Pharma and Biotech Professionals: What Actually Proves…

CDSCO to Introduce Integrated Drug Regulatory Platform in 18 Months

Resilience and Eli Lilly Expand Strategic Partnership with $750 Million Ohio…

WHO Introduces Global Regulatory Framework for Decarbonizing Pharmaceuticals

Why Operational Resilience is Becoming A Strategic Priority Across Pharmaceutical Facilities

The Engine of Cell Therapy Success: Why Analytical Development Determines Whether…

Stevanato Group and Syntegon Join Forces to Drive Innovation

Move Beyond Visibility: Why Cold Chain Orchestration is Now Essential for…

Speed in complex drug development is the late-phase outcome of early-phase…

The Evolution of Field Execution in Specialty Pharma: From Coverage to…

Container Closure Integrity by Design – From Clinical to Commercial Manufacturing

Syntegon Publishes 2025 Sustainability Report and Advances Sustainability Development

Shilpa Biologicals Launches Integrated ADC Production Site in India

CPHI Milan 2026 Unveils Dedicated Innovation Hubs for Pharma Manufacturing

Sanofi Partners with Pangaea for AI-Driven AATD Detection

Kuecept present at Procept Spray Drying seminar in Barcelona

O-1A Visa Evidence for Pharma and Biotech Professionals: What Actually Proves Extraordinary Ability

CDSCO to Introduce Integrated Drug Regulatory Platform in 18 Months

Resilience and Eli Lilly Expand Strategic Partnership with $750 Million Ohio Manufacturing Investment

Never miss a pharmaceutical headline

Container Closure Integrity by Design –...

Contract Manufacturing Supporting GLP-1 Market Expansion

Emerging GLP-1 Therapies Redefining Metabolic Treatment

AI Accelerating Next-Generation GLP-1 Drug Discovery

O-1A Visa Evidence for Pharma and...

CDSCO to Introduce Integrated Drug Regulatory...

Resilience and Eli Lilly Expand Strategic...

WHO Introduces Global Regulatory Framework for...

O-1A Visa Evidence for Pharma and Biotech Professionals: What Actually Proves Extraordinary Ability

CDSCO to Introduce Integrated Drug Regulatory Platform in 18 Months

Resilience and Eli Lilly Expand Strategic Partnership with $750 Million Ohio Manufacturing Investment

WHO Introduces Global Regulatory Framework for Decarbonizing Pharmaceuticals

About us

SUBSCRIBE US

System

RESOURCES

ARCHIVE LINKS

Subscribe

GLP-1 Capacity Expansion Reshaping CDMO Manufacturing

GLP-1 Therapies Broadening Clinical Treatment Pathways